{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:50:52Z","timestamp":1760266252717},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1053\/berh.1999.0083","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T21:49:59Z","timestamp":1027892999000},"page":"151-163","source":"Crossref","is-referenced-by-count":21,"title":["The anti-phospholipid antibody syndrome (Hughes syndrome): therapeutic aspects"],"prefix":"10.1053","volume":"14","author":[{"given":"Maria J.","family":"Cuadrado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munther A.","family":"Khamashta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/berh.1999.0083_RF1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.1999.0083_RF2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","article-title":"Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE disorders","volume":"112","author":"Love","year":"1990","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/berh.1999.0083_RF3","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/WNL.43.10.2069","volume":"43","year":"1993","journal-title":"Neurology"},{"key":"10.1053\/berh.1999.0083_RF4","doi-asserted-by":"crossref","first-page":"997","DOI":"10.7326\/0003-4819-117-12-997","article-title":"Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis","volume":"117","author":"Ginsburg","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/berh.1999.0083_RF5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0002-9343(96)00060-5","article-title":"Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four year prospective study from the Italian registry","volume":"100","author":"Finazzi","year":"1996","journal-title":"American Journal of Medicine"},{"key":"10.1053\/berh.1999.0083_RF6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.CIR.91.1.23","article-title":"Anticardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men","volume":"91","author":"Vaarala","year":"1995","journal-title":"Circulation"},{"key":"10.1053\/berh.1999.0083_RF7","first-page":"372","article-title":"Clinical consequences of antiphospholipid antibodies: an historic cohort study","volume":"83","author":"Silver","year":"1994","journal-title":"Obstetrics and Gynecology"},{"key":"10.1053\/berh.1999.0083_RF8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1191\/096120398678919624","article-title":"Outcome of patients with anticardiolipin antibodies: a 10 years follow-up of 52 patients","volume":"7","author":"Shah","year":"1998","journal-title":"Lupus"},{"key":"10.1053\/berh.1999.0083_RF9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/berh.1999.0083_RF10","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1177\/096120339300200104","article-title":"The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE","volume":"2","author":"Wallace","year":"1993","journal-title":"Lupus"},{"key":"10.1053\/berh.1999.0083_RF11","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1177\/096120339600500105","article-title":"Hydroxychloroquine use in the Baltimore lupus cohort: effects on lipids, glucose and thrombosis","volume":"5","author":"Petri","year":"1996","journal-title":"Lupus"},{"key":"10.1053\/berh.1999.0083_RF12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-76-3-112-6-423","article-title":"Very low doses of warfarin can prevent thrombosis in central venous catheters: a randomized prospective trial","volume":"112","author":"Bern","year":"1990","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/berh.1999.0083_RF13","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(94)90008-6","article-title":"Double-blind randomised trial of very low-dose warfarin for prevention of thromboembolism in stage IV breast cancer","volume":"343","author":"Levine","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/berh.1999.0083_RF14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-117-4-303","article-title":"Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients","volume":"117","author":"Rosove","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/berh.1999.0083_RF15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid antibody syndrome","volume":"332","author":"Khamashta","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/berh.1999.0083_RF16","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.1997.00440390101013","article-title":"A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis","volume":"157","author":"Krnic-Barrie","year":"1997","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/berh.1999.0083_RF17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9343(98)00060-6","article-title":"Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy","volume":"104","author":"Schulman","year":"1998","journal-title":"American Journal of Medicine"},{"key":"10.1053\/berh.1999.0083_RF18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199903253401201","article-title":"A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism","volume":"340","author":"Kearon","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/berh.1999.0083_RF19","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood.V86.10.3685.bloodjournal86103685","article-title":"Antiphospholipid antibodies and venous thromboembolism","volume":"86","author":"Ginsberg","year":"1995","journal-title":"Blood"},{"key":"10.1053\/berh.1999.0083_RF20","doi-asserted-by":"crossref","first-page":"23B","DOI":"10.1016\/0002-9149(95)80006-E","article-title":"Combined use of aspirin and warfarin in primary prevention of ischemic heart disease in men at risk","volume":"75","author":"Meade","year":"1995","journal-title":"American Journal of Cardiology"},{"key":"10.1053\/berh.1999.0083_RF21","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","article-title":"Thrombosis, abortion, cerebral disease and the lupus anticoagulant","volume":"287","author":"Hughes","year":"1983","journal-title":"British Medical Journal"},{"key":"10.1053\/berh.1999.0083_RF22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","article-title":"Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) Italian study on complications of oral anticoagulant therapy","volume":"348","author":"Palareti","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/berh.1999.0083_RF23","first-page":"1716","article-title":"Hemorrhagic complications of long-term anticoagulant therapy in 7 patients with systemic lupus erythematosus and antiphospholipid syndrome","volume":"24","author":"Al-Sayegh","year":"1997","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0083_RF24","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1161\/01.CIR.97.22.2195","article-title":"Antiphospholipid syndrome in the elderly: caution","volume":"97","author":"Piette","year":"1998","journal-title":"Circulation"},{"key":"10.1053\/berh.1999.0083_RF25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0889-857X(05)70351-3","article-title":"Antiphospholipid antibody syndrome in pediatric patients","volume":"23","author":"Ravelli","year":"1997","journal-title":"Rheumatic Disease Clinics of North America"},{"key":"10.1053\/berh.1999.0083_RF26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-127-3-199708010-00001","article-title":"Monitoring warfarin therapy in patients with lupus anticoagulants","volume":"127","author":"Moll","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/berh.1999.0083_RF27","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1046\/j.1365-2141.1997.3283145.x","article-title":"Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the antiphospholipid syndrome","volume":"98","author":"Lawrie","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1053\/berh.1999.0083_RF28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-199805000-00005","article-title":"Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients","volume":"77","author":"Asherson","year":"1998","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/berh.1999.0083_RF29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/ard.56.3.194","article-title":"Thrombocytopenia in the antiphospholipid syndrome","volume":"56","author":"Cuadrado","year":"1997","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.1999.0083_RF30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/rheumatology\/38.9.848","article-title":"Splenectomy for refractory thrombocytopenia in the antiphospholipid syndrome","volume":"38","author":"Galindo","year":"1999","journal-title":"Rheumatology"},{"key":"10.1053\/berh.1999.0083_RF31","first-page":"131","article-title":"A study of sixty pregnancies in patients with the antiphospholipid syndrome","volume":"14","author":"Lima","year":"1996","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1053\/berh.1999.0083_RF32","first-page":"93","article-title":"Antiphospholipid syndrome in pregnancy","volume":"11","author":"Langford","year":"1999","journal-title":"Contemporary Reviews in Obstetrics and Gynaecology"},{"key":"10.1053\/berh.1999.0083_RF33","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/oxfordjournals.humrep.a138009","article-title":"Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome","volume":"8","author":"Balasch","year":"1993","journal-title":"Human Reproduction"},{"key":"10.1053\/berh.1999.0083_RF34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0897.1993.tb00581.x","article-title":"The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome","volume":"29","author":"Krause","year":"1993","journal-title":"American Journal of Reproductive Immunology"},{"key":"10.1053\/berh.1999.0083_RF35","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1055\/s-0037-1615124","article-title":"Thromboprophylaxis in antiphospholipid syndrome pregnancies with previous cerebral arterial thrombotic events: is warfarin preferable?","volume":"79","author":"Hunt","year":"1998","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/berh.1999.0083_RF36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJM199707173370302","article-title":"Prednisolone and aspirin in women with antibodies and unexplained recurrent fetal loss","volume":"337","author":"Laskin","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/berh.1999.0083_RF37","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0002-9378(92)91596-3","article-title":"Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomised trial comparing prednisolone with low-dose heparin treatment","volume":"166","author":"Cowchock","year":"1992","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/berh.1999.0083_RF38","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0002-9378(97)70403-4","article-title":"Low-molecular-weight heparin for obstetric prophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk","volume":"176","author":"Nelson-Piercy","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/berh.1999.0083_RF39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/bmj.314.7076.245","article-title":"Antiphospholipid (Hughes') syndrome. A treatable cause of recurrent pregnancy loss","volume":"314","author":"Khamashta","year":"1997","journal-title":"British Medical Journal"},{"key":"10.1053\/berh.1999.0083_RF40","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/berh.1999.0083_RF41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant humans with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"British Medical Journal"},{"key":"10.1053\/berh.1999.0083_RF42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1191\/096120398678920451","article-title":"Use of intravenous immunoglobulin therapy in pregnancy in systemic lupus erythematosus and antiphospholipid syndrome","volume":"7","author":"Gordon","year":"1998","journal-title":"Lupus"},{"key":"10.1053\/berh.1999.0083_RF43","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1177\/096120339800700220","article-title":"Antiphospholipid antibodies and infertility: fact or fallacy","volume":"7","author":"Branch","year":"1998","journal-title":"Lupus"},{"key":"10.1053\/berh.1999.0083_RF44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1191\/096120399678847461","article-title":"Antiphospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS?","volume":"8","author":"Ijdo","year":"1999","journal-title":"Lupus"},{"key":"10.1053\/berh.1999.0083_RF45","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/0140-6736(90)91373-I","article-title":"Association of antibodies against phsopholipids with heart valve disease in systemic lupus erythematosus","volume":"335","author":"Khamashta","year":"1990","journal-title":"Lancet"},{"key":"10.1053\/berh.1999.0083_RF46","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0140-6736(93)92719-A","article-title":"Ischemic necrotic toes associated with the antiphospholipid syndrome and treated with iloprost","volume":"342","author":"Zahavi","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/berh.1999.0083_RF47","first-page":"772","article-title":"Primary antiphospholipid syndrome presenting as chronic thromboembolic pulmonary hypertension. Treatment with thromboendarterectomy","volume":"23","author":"Sandoval","year":"1996","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0083_RF48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0272-6386(12)80986-3","article-title":"Renal transplantation in anticardiolipin antibody-positive lupus eyrthematosus patients","volume":"23","author":"Radhakrishnan","year":"1994","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1053\/berh.1999.0083_RF49","first-page":"2159","article-title":"Systemic therapy with fibrinolytic agents and heparin for recalcitrant non-healing cutaneous ulcer in the antiphospholipid syndrome","volume":"21","author":"Gertner","year":"1994","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0083_RF50","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0002-9343(99)00053-4","article-title":"Serum anti-\u03b22-glycoprotein I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients","volume":"106","author":"Gomez-Pacheco","year":"1999","journal-title":"American Journal of Medicine"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694299900839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694299900839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T17:21:50Z","timestamp":1583428910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694299900839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S1521694299900839"],"URL":"https:\/\/doi.org\/10.1053\/berh.1999.0083","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}